The peritoneal exudate cells (PEC) represent the first line of defence against the virus in the mouse model of intraperitoneal (i.p.) infection with herpes simplex virus (HSV). We have therefore studied interferon production and activation of natural killer (NK) cells in vitro in PEC of HSV-injected mice. Injection of HSV caused a marked increase in NK cell activity, as reported by others. PEC from HSV-injected mice also produced high titres of interferon. This observation may be important since induction of interferon appears to be the primary event whereas activation of NK cells -as generally accepted -represents a secondary effect of the interferon produced. The HSV-induced NK cells shared the properties of NK cells in that they were sensitive to a monoclonal anti-theta antibody and to a monoclonal anti-Qa 5 antibody. In contrast, the cells producing interferon were not sensitive to either antibody. Irradiation (200 R) of the mice 24 h before injection of the virus decreased interferon production by more than 90%. The identity of the interferon-producing ceils is unknown, but they may represent B cells.
INTRODUCTION
The mouse model of intraperitoneal (i.p.) infection with herpes simplex virus (HSV) has been utilized widely to study antiviral defence mechanisms (e.g. see Andervont, 1929; Johnson, 1964; Zisman et al., 1970; Stevens & Cook, 1971; Lopez, 1975; Kirchner et al., 1978) . In this model, mice die from encephalitis 7 to 10 days after infection. It appears, that the first line of defence is represented by the peritoneal macrophages. Thus, Stevens & Cook (1971) have shown that macrophages from adult mice are able to actively restrict virus replication whereas macrophages from newborn mice are permissive for replication of HSV, thus allowing further spread of the virus. The well-established difference in susceptibility to HSV between newborn and adult mice has been attributed to this difference on the macrophage level. However, the situation appears to be more complex, since recently it has been established that adult mice of certain inbred strains are highly susceptible to i.p. infection with HSV (Lopez, 1975 (Lopez, , 1978 Kirchner et al., 1978) .
We have recently started a series of experiments in which we have analysed various systemic parameters of antiviral immunity and non-specific defence in HSV-infected adult mice (Zawatzky et al., 1981) . We have also presented a preliminary report on a comparison between a pathogenic and an apathogenic strain of HSV (Schrtder et al., 1981) . In extension of these studies we have analysed a number of functional parameters at the injection site, i.e. in the peritoneal cavity. These studies include an analysis of local interferon production and of activation of natural killer (NK) cells.
METHODS
Virus. HSV-1 (WAL) and HSV-1 (ANG) were prepared as described previously (Schrtder et al., 1981) . In all experiments but one, HSV-1 (WAL), subsequently referred to as HSV, was used. In one experiment (Table 3) a comparison was performed between HSV-1 (WAL) and HSV-1 (ANG). As previously shown (SchrSder et al., 1981) HSV-1 (ANG) is apathogenic for mice after i.p. infection whereas HSV-1 (WAL) is pathogenic.
Animal model. All details of our HSV model have been previously described (Zawatzky et al., 1981) . Male C57BL/6J BOM mice (GI. Bomholtgard Ltd., Ry, Denmark) were used when 10 to 14 weeks old. Mice were injected i.p. with 106 or 107 p.f.u, of HSV and 18 h later, the mice were killed and the PEC were recovered. The total cell count of PEC from HSV-injected mice was increased two-to threefold as compared to uninjected controls, but the percentage of phagocytic cells, as determined by phagocytosis of carbon particles or by neutral red staining, was about 30% in both experimental animals and controls.
The cells were washed twice by centrifugation, counted and assayed for interferon production and NK cell activity. Treatment of the PEC by anti-theta serum plus complement was performed as previously described for spleen cells (Kirchner et al., 1980) . Cytotoxic treatment of PEC by monoclonal anti-Qa 4 and anti-Qa 5 antibodies was performed as previously described utilizing selected rabbit complement (Koo et al., 1980) . In order to test the effect of irradiation, mice were irradiated with 200 R using a 6°Co source (Gammatron, Siemens) and injected 24 h later with HSV. The PEC were recovered 18 h later for testing.
Interferon induction. In this test, PEC at a ceil concentration of 2 × 105 per 0.2 ml of tissue culture medium (RPMI 1640 supplemented with glutamine, antibiotics and 5 % foetal bovine serum) were incubated for 24 h in the wells of 96-weU plates (Falcon). The cell-free supernatants were recovered and frozen at -70 °C until estimation of interferon titres were performed. Details of the interferon assay as used in our laboratory have been described previously (Zawatzky et al., 1981) .
Assay of NK cell activity. The target cell chosen for testing of NK cell activity was YAC-1, a lymphoma of A/J mice which is the target most commonly used in such studies. It was kindly provided to us by K. Kfirre (Department of Tumor Biology, Karolinska Institute, Stockholm, Sweden) and was mycoplasma-free.
YAC-1 target cells were incubated at 37 °C with SlCr (1 mCi/ml, sp.act. 200 to 500 Ci/g; New England Nuclear), at a concentration of 50 #1 5~Cr/106 cells. After 90 rain the targets were washed three times with RPMI 1640 and adjusted to a concentration of 105 cells/ml. PEC were tested at three different concentrations (1 x 106, 5 × 105, 2.5 × 105 cells/ml). 100 gl of PEC were mixed with 100 #1 of the target cell preparation in the wells of a 96-well plate (Falcon) and incubated for 4 h. For the low control values untreated targets were incubated; for high control values the target cells were lysed by treatment with Triton X-100. Release of S~Cr into the supernatant was measured and the specific StCr release was calculated according to the following formula:
Test release --Low control release % Specific lysis = 100 x High control release -Low control release et al., 1981) . § For this part of the experiment, mice were irradiated with 200 R 24 h before injection of virus and PEC were recovered at the same time as those of unirradiated mice used in the same experiment.
RESULTS

Interferon induction in PEC after injection of HSV
PEC from C57BL/6 mice were recovered 18 h after injection of HSV and placed in tissue culture without adding any further stimulant for another 24 h. High titres of interferon were observed in the cell-free supernatants of these cultures (Table 1 ). In contrast, no interferon was found in the supernatants of PEC from untreated control mice or mice injected with various control preparations. The latter included virus pools freed of virions by ultracentrifugation or of supernatants from cells of the type in which the HSV pool had been prepared.
In various additional experiments (not shown here) we have analysed the phenomenon of HSV-induced interferon production by PEC in more detail. Kinetic studies, dose-response curves and comparison of different tissue culture conditions indicated that the conditions used in the experiment of Table 1 are optimal. Furthermore, we have shown that the antiviral principle elaborated in this system was not removed by ultracentrifugation but was sensitive to trypsin treatment. It fulfilled the criteria of a type I interferon, since it was neutralized by an anti-type I interferon and was stable at pH 2.
Treatment of HSV-induced PEC by anti-theta serum plus complement did not diminish interferon production. In addition, treatment by either anti-Qa 5 or anti-Qa 4 did not affect interferon production. However, the interferon-producing cell was inactivated when the mice received 200 R of whole-body irradiation 24 h before injection of HSV (Table 1) .
Activation of NK cells by injection of HSV
Similarly to the data of Armerding et al. (1981) we have found that spleen cells of C57BL/6 mice 18 h after injection of HSV showed increased NK cell activity (Table 2) . NK cell activity in the PEC of mice was also greatly increased 18 h after injection of HSV. Again no increase in NK cell activity was seen after injection of control preparations (data not shown). Treatment of PEC with anti-theta serum decreased NK cell activity by about 70 %. Treatment with anti-Qa 5 completely abolished NK cell activity and partial depletion was observed after treatment with anti-Qa 4. * C57BL/6 mice were injected i.p. with HSV and 18 h later spleen cells or PEC were recovered. They were tested for NK cell activity against YAC-1 at a ratio of 30 : 1 (spleen) or 10 : 1 (PEC). 
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Comparison between HSV-1 (WAL) and HSV-1 (ANG)
We have recently reported that in contrast to HSV-1 (WAL), which is highly pathogenic for mice after i.p. infection, HSV-1 (ANG) is apathogenic even when high virus doses are injected (Schr6der et al., 1981) . We wished to compare interferon production and NK cell activation in the peritoneal exudate of B6 mice after injection of the different virus strains. As shown in Table 3 , no differences between the two viruses were observed in either assay. Thus, our previous speculation (Schr6der et al., 1981) that there are differences between the levels of NK cell activity induced by HSV-1 (WAL) and HSV-1 (ANG) did not stand a thorough investigation.
DISCUSSION
Two effects of injection of HSV in the peritoneal cavity of mice have recently been reported by Armerding et al. (1981) . The first phenomenon was activation of macrophages which was measured by the increase of phagocytic activity. Similarly, Morahan et al. (1980) have reported increased antiviral activity of macrophages from HSV-injected mice, an effect they have termed 'extrinsic antiviral activity'.
The second effect, which Armerding et al. (1981) have reported and which was confirmed in our paper, was activation of NK cells. Obviously, many different viruses are able to activate NK cells in vivo and most likely this activation is an indirect effect caused by virus-induced interferon which then in turn activates NK cells (Welsh, 1978) . There have been recent papers suggesting that such activated NK ceils may be different from 'naturally occurring' NK cells, for example the NK cells that are present in the spleens of nude mice (McFarlan et al., 1979) . This question was not addressed in our paper. However, we have found that the NK cell activity of PEC from HSV-injected mice was significantly reduced by treatment with anti-theta serum plus complement, in agreement with data of Herberman et aL (197'8) who have reported the sensitivity of NK cells to anti-theta serum. Additionally, we have found that HSV-induced NK cell activity was abolished by treatment with anti-Qa 5. Koo et al. (1980) have shown that the sensitivity to this antisera is a typical marker for NK cells. Thus, our data seem to suggest that HSV-induced NK ceils are similar to 'normally occurring NK cells'. Armerding et al. (1981) presented a more extensive analysis of HSV-induced non-specific killer cells and as it appears they share all the properties currently ascribed to NK cells.
Because of the well-established link between interferon and NK cell activation it is not surprising that we have also found interferon production by PEC after injection of HSV. In fact, the same connection holds true for macrophage activation because macrophage activation is also known to occur as a consequence of interferon action (Huang et al., 1971) . Thus, one might speculate that the primary effect of HSV in the PE population is interferon induction whereas activation of NK cells and macrophages are secondary effects. At the moment it is not clear if macrophages and/or NK cells play a role in the local antiviral defence and one could speculate that measurement of NK cell and macrophage activation represent effects secondary to interferon induction and are less important than one would like to think. One might also speculate that other lymphokines produced by activated T cells play a role in this reaction. However, in the non-immune state the most prominent mediator molecule produced upon viral challenge is interferon.
We do not know the identity of the interferon-producing cell in the PEC. Preliminary data shown above suggest that it may be a cell type similar to that producing interferon in HSV-treated spleen cell cultures, since it was radiosensitive, not sensitive to anti-theta serum and it was present in PEC from nude mice (results not shown). In our previous studies, although based partially on indirect evidence, we have concluded that the splenic producer cell of interferon in response to HSV may be a B cell (Kirchner et al., 1980) . It remains to be seen if the same is true for the PEC population. It is, however, known that there is a subpopulation of B cells present in the peritoneal exudate (Nathan et al., 1977) .
Presently our laboratory is working on a comparison between pathogenic and apathogenic strains of HSV in regard to antiviral defence mechanisms (Schr6der et al., 1981) . In the present paper we have found that the pathogenic and the apathogenic virus strain do not differ in their capacity to induce interferon production and NK cell activation. Thus, if the reasons for pathogenicity versus apathogenicity are to be sought on the level of antiviral defence, obviously they cannot be explained by either of these two functions. However, the reason for pathogenicity of a virus strain may be caused by properties of the target cell of infection and not at all by defence mechanisms.
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